Top trades by Australian Sharesight users — February 2026

Welcome to the February 2026 edition of Sharesight’s monthly trading snapshot for Australian investors, where we look at the top 20 trades made by Australian Sharesight users. Below we will look at the top trades overall, plus the top trades in individual stocks, which allows us to observe the broader investment trends by Australian Sharesight users, while also giving us an opportunity to zoom into the most popular stocks and the market-moving news behind them.

Top trades in February 2026

Note: To get a closer look at this chart, you can right-click and open the image in a new tab (for desktop) or press-hold and download the image or open it in a web browser (for mobile).

For the second consecutive month, the top trades were led by Vanguard’s MSCI Index International Shares (ASX: VGS) and iShares’ S&P 500 (ASX: IVV) ETFs. In terms of individual equities, the most-traded stock was once again WiseTech Global (ASX: WTC), which made headlines by announcing its intention to cut 30% of its global workforce. It was an extremely ETF-heavy month overall, with 9 of the top 20 trades consisting of ETFs.

Most-traded stocks in February 2026

Note: To get a closer look at this chart, you can right-click and open the image in a new tab (for desktop) or press-hold and download the image or open it in a web browser (for mobile).

This month’s top-traded stocks were led by WiseTech Global (ASX: WTC), with many Sharesight users buying the dip. The top trades were followed by CSL (ASX: CSL), which has continued to trade at multi-year lows.

Let’s look at some of the market-moving news behind some of this month’s top stocks:

WiseTech Global (ASX: WTC)

• WiseTech cuts global workforce by 30%
• WiseTech shares down 65% YoY and 37% YTD amid tech selloff

CSL (ASX: CSL)

• CSL shares plunge 12% following weak half-year earnings and surprise CEO exit
• CSL expands share buy-back program

Microsoft (NASDAQ: MSFT)

• Microsoft gets a rare downgrade due to ‘overoptimistic revenue and earnings expectations’
• After a 15% YoY decline, is Microsoft set for a comeback?

Xero (ASX: XRO)

• Xero share price hits 3-year low, with investors concerned about US expansion strategy
• AI fears send Xero shares down, along with other software stocks

Pro Medicus (ASX: PME)

• Pro Medicus shares plummet 22% despite strong earnings and record margins
• Shares rally after recent sell-off

BHP (ASX: BHP)

• BHP shares hit record high following announcement of outsized dividend and US$4.3 billion silver deal
• Are BHP shares a solid income play after 46% dividend hike?

NVIDIA (NASDAQ: NVDA)

• Investors sell off NVIDIA shares as OpenAI investment stalls
• Plans to lease data centre with US$3.8 billion in junk bonds; CEO backs US$660 billion AI investment by its key clients

Track your investment portfolio with Sharesight

Get access to insights like this by tracking your investment portfolio with Sharesight. Built for the needs of investors like you, with Sharesight you can:

• Track all your investments in one place, including stocks, mutual/managed funds, property, and even cryptocurrency
• Get the true picture of your investment performance, including the impact of brokerage fees, dividends, and capital gains with Sharesight’s annualised performance calculation methodology
• Run powerful reports built for investors, including performance, portfolio diversity, contribution analysis, exposure, drawdown risk, multi-period, multi-currency valuation and future income
• Run tax reports including taxable income (dividends/distributions), Capital Gains Tax (Australia and Canada), Traders Tax (Capital Gains for traders in NZ) and FIF foreign investment fund income reports (NZ)

Sign up for a FREE Sharesight account and get started tracking your investments today.

Disclaimer: The above article is for informational purposes only and does not constitute a specific product recommendation, or taxation or financial advice and should not be relied upon as such. While we use reasonable endeavours to keep the information up-to-date, we make no representation that any information is accurate or up-to-date. If you choose to make use of the content in this article, you do so at your own risk. To the extent permitted by law, we do not assume any responsibility or liability arising from or connected with your use or reliance on the content on our site. Please check with your adviser or accountant to obtain the correct advice for your situation.

FURTHER READING

• Subscribe to Sharesight20 trading snapshots
• How Sharesight calculates your investment performance
• Sharesight users' top trades – January 2026